Migraine Treatment with Vomiting
Introduction to Migraine Treatment
- The American Academy of Family Physicians recommends using a non-oral route of administration for migraine accompanied by vomiting, with metoclopramide 10 mg IV plus ketorolac 30 mg IV as first-line treatment, or sumatriptan 6 mg subcutaneously if NSAIDs are contraindicated 1
Rationale for Avoiding Oral Route
- The presence of vomiting renders oral treatments ineffective, even if they are theoretically appropriate, due to gastroparesis preventing adequate absorption of oral medications 2, 1
First-Line Treatment Protocol
- The combination of metoclopramide 10 mg IV and ketorolac 30 mg IV treats pain, nausea, and vomiting simultaneously, with ketorolac having a rapid onset of action and minimal risk of rebound headache 1
- Sumatriptan 6 mg subcutaneously is an effective and rapid option for moderate to severe migraines with vomiting, providing pain relief in 70-82% of patients within 15 minutes, with 59% completely relieved at 2 hours 1
Specific Antiemetic Treatment
- Metoclopramide should not be reserved only for patients who vomit, as nausea itself is one of the most debilitating symptoms of migraine and justifies treatment 1, 3
Critical Pitfall to Avoid
- The use of all rescue medications should be strictly limited to a maximum of 2 days per week to prevent medication-overuse headaches, which can paradoxically increase the frequency of attacks and lead to daily headaches 1, 3
- If a patient requires rescue treatment more than 2 times a week, preventive treatment (propranolol 80-240 mg/day, timolol 20-30 mg/day, or divalproex sodium 500-1500 mg/day) should be initiated immediately 2, 1
Contraindications and Precautions
- The American Academy of Family Physicians advises against using opioids (hydromorphone, oxycodone) except as a last resort, as they promote dependence, rebound headaches, and loss of efficacy 2, 1
- Oral medications (including oral triptans or NSAIDs) should be avoided in the presence of active vomiting 2, 1
- Acetaminophen alone is ineffective for migraine treatment 2